ABCB1 and cancer: Here, the importance of the generous expression of the agent's target—integrin αvβ3 with the tetrac receptor—on cancer cells is critical, so that conventional and necessary activity of MDR1 in nonmalignant tissues is unimpaired in the presence of nanotetrac.